Clinical Trials Logo

Clinical Trial Summary

This study will evaluate the long-term sequelae of COVID-19 in patients diagnosed with COVID-19 who previously enrolled in a RO7496998 (AT-527) study (i.e. parent study), for approximately 6 months after the end of the parent study.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05059080
Study type Observational
Source Atea Pharmaceuticals, Inc.
Contact CV43140
Phone 888-662-6728 (U.S. Only)
Email [email protected]
Status Recruiting
Start date June 15, 2021
Completion date May 6, 2022